Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold

Fig. 5

iso1Au/TNF increases the tumor cell uptake of Doxo. WEHI-164 tumor-bearing mice (approximately 0.4–0.8 cm in tumor diameter) were treated i.v. with vehicle or the indicated dose of doxo alone or in combination with iso1Au/TNF. After 2 h, tumors were recovered, weighed, minced, and processed as described previously [3] to obtain a single-cell suspension, and analyzed by flow cytometry. a Representative flow cytometry analysis of WEHI-164 tumor cells recovered from mice treated as indicated. The M1 dotted line indicates the fluorescence interval considered positive. b Mean fluorescence intensity (left) and percentage of positive cells in the M1 area (right). Cumulative results of 2 independent experiments (mean ± SE, 2–3 mice/experiment). *P < 0.05; **P < 0.01, ***P < 0.001, by two-tailed t-test

Back to article page